Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluzone Quadrivalent Full vs Half Dose in Children 6-35 Months
NCT02915302Phase 4Completed
- Sponsor
- Sanofi
- Start
- Sep 2016
- Primary completion
- Mar 2017
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 2
01
Overview
Phase 4, randomised, single-blind trial of Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated) in influenza (2 arms), sponsored by Sanofi. Primary endpoint: Percentage of Participants With Fever at 7 days. Started Sep 2016; status: completed.
02
Drugs
Influenza B virus B/Phuket/3073/2013 hemagglutinin antigen (formaldehyde inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02915302.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02915302.